Mitomycin C-Based Hyperthermic Intraperitoneal Chemotherapy Improves Survival in Colorectal Cancer With Peritoneal Metastasis

20260 citationsJournal Articlediamond Open Access

Authors

Chayanit Sirisai · National Cancer Institute of Thailand

Hathaiwan Moungthard · National Cancer Institute of Thailand

Kitinut Timudom · National Cancer Institute of Thailand

Saipan Khunpakdee · National Cancer Institute of Thailand

Abstract

CRS combined with MMC-based HIPEC provides a significant survival benefit for selected patients with colorectal cancer and isolated peritoneal metastasis. These findings support the role of MMC-based HIPEC as an effective locoregional treatment strategy.

Topics & Keywords

Intraperitoneal and Appendiceal Malignancies Nanoplatforms for cancer theranostics Intestinal and Peritoneal Adhesions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cureus

Volume 18, Issue 1, pp. e102405-e102405

DOI: 10.7759/cureus.102405

Field-Weighted Citation Impact: 0.00